Format

Send to

Choose Destination
See comment in PubMed Commons below
Gynecol Oncol. 2007 Nov;107(2):219-22. Epub 2007 Jul 25.

Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study.

Author information

1
Department of Gynaecology, University Hospital of Aarhus, Skejby, DK-8200 Aarhus N, Denmark. OMA@sks.aaa.dk

Abstract

OBJECTIVE:

To investigate the effect of topical imiquimod in patients with vulvar intraepithelial neoplasia (VIN).

METHODS:

We used a prospective, randomised, double-blinded, placebo-controlled study. Women with biopsy verified, visible VIN2 or VIN3, in a biopsy not older than 2 months were considered.

RESULTS:

Thirty-two patients were included, one was excluded before treatment. Twenty-one received active treatment, 10 received placebo. Seventeen (81%) in the treatment group showed complete response, two (10%) partial response and none responded in the placebo-group when evaluated by a biopsy 2 months after a treatment period of 16 weeks. Fourteen of 21 patients (67%) in the treatment group had to reduce the number of applications due to local side-effects.

CONCLUSION:

The topical treatment with imiquimod 5% was shown in this setting to be very efficient. Local side effects were a common feature, but tolerable after dose reduction. Long-term results are not known, but a planned cohort study of this population will show the rate of recurrences.

PMID:
17655918
DOI:
10.1016/j.ygyno.2007.06.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center